Skip to main content

College of
Health Sciences

Ryley Uber

Pharmacogenomics Program Director
Clinical Assistant Professor, Geisinger Center for Pharmacy Innovation and Outcomes

57 100 N Academy Avenue
Danville, PA 17822
Phone: 570-214-7388

Ryley Uber, PharmD

Research Interests

Pharmacogenomics implementation, improving minority health with pharmacogenomics, the impact of pharmacogenomics on the variability of psychiatric medications, the clopidogrel and CYP2C19 drug-gene interaction, and machine learning.

Recent Publications

  • Uber R, Wright E. Pharmacogenomics implementation and multidisciplinary genomics collaboration: Real-world experience from Geisinger. Am J Health Syst Pharm. 2022 Mar 12;zxac065. Full Text
  • Writer R, Barthen C, Antinopoulos B, Uber R, Stevenson JM, Berenbrok LA. How community pharmacists envision using pharmacogenomic data: A qualitative analysis. J Am Pharm Assoc (2003). Sep-Oct 2021;61(5):e64-e70. Full Text
  • Rosengart A, Collins MK, Hendrix P, Uber R, Sartori M, Jain A, Mao J, Goren O, Schirmer CM, Griessenauer CJ. P2Y12 inhibitors in neuroendovascular surgery: An opportunity for precision medicine. Interv Neuroradiol. 2021 Oct;27(5):682-694. Full Text
  • Mehta D, Uber R, Ingle T, Li C, Liu Z, Thakkar S, Ning B, Wu L, Yang J, Harris S, Zhou G, Xu J, Tong W, Lesko L, Fang H. Study of pharmacogenomic information in FDA-approved drug labeling to facilitate application of precision medicine. Drug Discov Today. 2020 May;25(5):813-820. Full Text


Doctor of Pharmacy, Cedarville University, 2018
Clinical Pharmacogenomics Fellowship, University of Pittsburgh, 2020
Content from General Links with modal content